Close Menu
Home » CMS Reopens National Coverage Determination for NGS Testing in Advanced Cancer

CMS Reopens National Coverage Determination for NGS Testing in Advanced Cancer

May 01, 2019
|
staff reporter

NEW YORK (GenomeWeb) – The Centers for Medicare & Medicaid Services have officially reopened its national coverage determination for next-generation sequencing for advanced cancer patients in order seek public comments on germline testing. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Project to Discuss Race and Genetics in Class

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

Taking It All On

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

PLOS Papers on ASD-Related Syndrome, Twin Gut Microbiomes, Zika Virus Evolution

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

Unexpected Close

GenomeWeb reports that Veritas Genetics is suspending its US operations.

Featured White Papers

By National Decision Support Company, a Change Healthcare company
The New PAMA Math: Laboratory Data Key to Overcoming Medicare Cuts

What's Popular?

In Reimbursement News

  1. Local Coverage Determinations Roundup: Transplant Genomics, Opko Health

  2. Palmetto Issues Final LCD for Decipher Biosciences Prostate Cancer Test

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.